Drugs / AIC263029
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07503561 | Jun → Sep 2026 overdue | polyomavirus infectious disease | AiCuris Anti-infective Cures AG | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AIC263029 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07503561 ↗ |
| Route | Subcutaneous | “administered by subcutaneous injection” NCT07503561 ↗ |